Protein carbamylation links inflammation, smoking, uremia and atherogenesis
- 9 September 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 13 (10), 1176-1184
- https://doi.org/10.1038/nm1637
Abstract
Post-translational modification and functional impairment of proteins through carbamylation is thought to promote vascular dysfunction during end-stage renal disease. Cyanate, a reactive species in equilibrium with urea, carbamylates protein lysine residues to form epsilon-carbamyllysine (homocitrulline), altering protein structure and function. We now report the discovery of an alternative and quantitatively dominant mechanism for cyanate formation and protein carbamylation at sites of inflammation and atherosclerotic plaque: myeloperoxidase-catalyzed oxidation of thiocyanate, an anion abundant in blood whose levels are elevated in smokers. We also show that myeloperoxidase-catalyzed lipoprotein carbamylation facilitates multiple pro-atherosclerotic activities, including conversion of low-density lipoprotein into a ligand for macrophage scavenger receptor A1 recognition, cholesterol accumulation and foam-cell formation. In two separate clinical studies (combined n = 1,000 subjects), plasma levels of protein-bound homocitrulline independently predicted increased risk of coronary artery disease, future myocardial infarction, stroke and death. We propose that protein carbamylation is a mechanism linking inflammation, smoking, uremia and coronary artery disease pathogenesis.Keywords
This publication has 43 references indexed in Scilit:
- Carbamylated low-density lipoprotein induces death ofendothelial cells: A link to atherosclerosis in patients with kidney diseaseKidney International, 2005
- Carbamoylation of amino acids and proteins in uremiaKidney International, 2001
- Impaired Biological Activity of Erythropoietin by Cyanate CarbamylationBlood Purification, 2000
- Complement C4 Phenotypes in Patients with End-Stage Renal DiseaseNephron, 1996
- Factors determining hemoglobin carbamylation in renal failureKidney International, 1995
- Decreased clearance of uraemic and mildly carbamylated low‐density lipoproteinEuropean Journal of Clinical Investigation, 1994
- Hemoglobin Carbamylation in UremiaThe New England Journal of Medicine, 1981
- Gel isoelectric focusing for following the successive carbamylations of amino groups in chymotrypsinogen AAnalytical Biochemistry, 1971
- Reactions of Cyanate with Functional Groups of Proteins. II. Formation, Decomposition, and Properties of N-Carbamylimidazole*Biochemistry, 1965
- Reactions of the Cyanate Present in Aqueous Urea with Amino Acids and ProteinsPublished by Elsevier BV ,1960